DIPPER trial protocol: A multi-centre, randomised trial of salvage radiotherapy versus surveillance for biochemical recurrence after radical prostatectomy (ANZUP 2002).
Matthew John RobertsCiara ConduitIan D DavisRachel M EffeneyScott WilliamsJarad M MartinMichael S HofmanGeorge HrubyRenu EapenChristopher GianacasNathan PapaRichard De Abreu LourençoHaryana M DhillonRay AllenAntoinette FontelaBaldeep KaurLouise Emmettnull nullPublished in: BJU international (2023)
Eligible participants have PSA recurrence of prostate cancer following radical prostatectomy, defined by serum PSA 0.2-0.5ng/mL, deemed low risk according to modified European Association of Urology (EAU) biochemical recurrence risk criteria (ISUP Grade Group ≤2, PSA doubling time more than 12 months), with no definite/probable recurrent prostate cancer on PSMA-PET/CT.